Position in BMY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,295,470
+$71,857 QoQ
Shares Held
22,483
+11.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,027
of 2,506 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pure Financial Advisors, LLC holds $38,114,911 across 13 Drug Manufacturers - General names. BMY ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,010 | $8,408,005 | |
| 2 | MRK |
Merck & Co., Inc.
|
59,640 | $7,663,740 | |
| 3 | JNJ |
Johnson & Johnson
|
29,199 | $7,415,670 | |
| 4 | ABBV |
AbbVie Inc.
|
23,887 | $6,010,924 | |
| 5 | AMGN |
Amgen Inc
|
7,972 | $2,886,820 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
22,483 | $1,295,470 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,775 | $982,293 | |
| 8 | NVO |
Novo Nordisk A S
|
16,779 | $804,385 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,295,470 | 22,483 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,223,613 | 20,175 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $806,079 | 14,944 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $555,496 | 12,317 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $575,708 | 12,437 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $559,522 | 9,174 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $441,620 | 7,808 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $272,669 | 5,270 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $213,339 | 5,137 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $288,123 | 5,313 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $360,657 | 7,029 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $332,569 | 5,730 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $450,144 | 7,039 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $533,479 | 7,697 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $488,828 | 6,794 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $508,435 | 7,152 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $354,585 | 4,605 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $329,292 | 4,509 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $233,313 | 3,742 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $210,526 | 3,558 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $230,261 | 3,446 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $221,965 | 3,516 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $216,298 | 3,487 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $210,231 | 3,487 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $205,035 | 3,487 | Shares | Sole | 2020-07-08 | |
| No filing history on record for this holder in this stock. | ||||||